The formal notification of the United States’ intent to withdraw from the World Health Organization (WHO) has prompted a comprehensive defense from the international health body, which characterizes the move as a setback for global collective security. As a founding member and historically the largest contributor to the WHO’s budget, the United States has played a central role in shaping global public health policy since the organization’s inception in 1948. The decision, which is slated for review by the WHO Executive Board in February and the World Health Assembly in May 2026, marks a significant rupture in the postwar architecture of international cooperation.
Historical Context and the Role of the United States
For over seven decades, the United States has been an indispensable partner in the WHO’s most significant achievements. From the successful eradication of smallpox in 1980—a monumental milestone in medical history—to ongoing efforts to combat polio, HIV/AIDS, Ebola, and malaria, the U.S. has provided both financial resources and scientific expertise. The organization’s mandate, which covers everything from antimicrobial resistance to food safety and environmental health, has relied heavily on American participation.
The withdrawal notification, however, signals a fundamental shift in the U.S. approach to multilateral health governance. Critics within the U.S. government have characterized the WHO as an organization that has been "trashed and tarnished," alleging that it has compromised its independence and succumbed to bureaucratic agendas driven by geopolitical rivals. The WHO leadership, in turn, has consistently rejected these allegations, emphasizing its status as an impartial, UN-specialized agency governed by 194 Member States.
Chronology of the COVID-19 Response
Central to the friction between Washington and the WHO are the events of early 2020. The U.S. administration alleged that the WHO failed to provide transparent information during the initial stages of the COVID-19 outbreak, accusing the body of "concealing failures." To counter these claims, the WHO has pointed to its detailed internal timeline of actions taken during the crisis.
The sequence of events, according to the WHO, began on December 31, 2019, when the organization first received reports of a "pneumonia of unknown cause" in Wuhan, China. The WHO’s emergency incident management system was activated immediately. By January 11, 2020—the date the first death was officially reported—the organization had already disseminated alerts through public statements and global health networks.
On January 30, 2020, WHO Director-General Tedros Adhanom Ghebreyesus declared COVID-19 a Public Health Emergency of International Concern (PHEIC). At that juncture, official data showed fewer than 100 cases outside of China, and zero reported deaths internationally. Throughout the subsequent weeks, the Director-General issued a series of increasingly urgent warnings, famously stating that "the window of opportunity is closing" and describing the virus as "public enemy number one."
The WHO maintains that while no organization could have achieved a flawless response to an unprecedented global disruption, its guidance remained rooted in the best available scientific evidence. The organization explicitly notes that it never mandated masks, vaccines, or lockdowns; rather, it provided technical recommendations while leaving the implementation of sovereign policy to individual governments.
Analysis of Institutional Performance and Reforms
The fallout from the pandemic led to multiple independent reviews of the WHO’s performance. These evaluations, conducted by various panels of experts, highlighted the need for structural reforms within the International Health Regulations (IHR) framework. In response, the WHO has moved to strengthen its surveillance, laboratory capacity, and coordination mechanisms.
Data from the organization’s pandemic preparedness programs indicate that its 24/7 emergency monitoring systems remain vital for global safety. These systems are designed to detect emerging pathogens before they reach the scale of a global pandemic. Despite the criticism, the WHO emphasizes that its core mission is to serve as a neutral platform for scientific collaboration, regardless of the political tensions that may exist between its Member States.
Broader Implications for Global Health Governance
The prospect of a U.S. departure carries profound implications for global health security. The U.S. has historically been a key advocate for equitable access to medical countermeasures. If the withdrawal proceeds, the global health landscape may face a significant funding gap and a reduction in the collaborative research that underpins global preparedness.
Conversely, the WHO continues to push for new legal instruments to prevent future crises. A major development in this area is the adoption of the WHO Pandemic Agreement, which, once ratified, will represent a landmark in international law. The agreement aims to create a binding framework for pandemic prevention, preparedness, and response. Furthermore, negotiations are currently underway for an annex to this agreement, known as the Pathogen Access and Benefit Sharing (PABS) system. This system is intended to facilitate the rapid sharing of pathogen samples and ensure that the resulting vaccines, diagnostics, and therapeutics are distributed equitably across the globe, particularly to low- and middle-income countries.
Official Responses and the Future of Cooperation
In its official statements, the WHO has adopted a tone of regret, tempered by an invitation for future reconciliation. The organization asserts that it remains committed to the principle that the highest attainable standard of health is a fundamental human right.
The WHO leadership has repeatedly noted that they engage with the United States with "full respect for its sovereignty," and that they continue to cooperate with the U.S. scientific community, which remains deeply integrated into global health networks. The rhetoric from the U.S. government regarding a "politicized agenda" is viewed by the WHO as a misunderstanding of the organization’s governance structure. As a body governed by 194 nations, the WHO argues that it is inherently a forum for debate, but that its technical advice remains independent of the political interests of any single member.
The Path Forward
The period leading up to the May 2026 World Health Assembly will be a critical juncture for international health policy. The discussions held by the WHO Executive Board in February will likely serve as a barometer for how the organization plans to address the grievances raised by the United States and other member nations.
For the international community, the challenge lies in balancing the need for sovereign autonomy with the undeniable reality that infectious diseases do not respect national borders. The WHO argues that the systems it manages are not merely bureaucratic, but are the primary defense against the next global health threat. Whether the U.S. will ultimately reverse its decision remains a matter of ongoing diplomatic speculation. In the interim, the WHO continues its work, emphasizing that its survival and efficacy are inextricably linked to the continued, active participation of all major world powers.
As the global community reflects on the lessons of the COVID-19 pandemic, the debate surrounding the WHO’s future underscores a wider tension in the 21st century: the difficulty of maintaining effective, evidence-based multilateralism in an era of deepening geopolitical fragmentation. The WHO maintains that its doors remain open and that the global health challenges of the future—from climate change to the threat of novel pathogens—are too large for any single nation to address in isolation. The organization’s focus remains on navigating these political headwinds while fulfilling its constitutional mandate to protect the health of all people, a task it insists requires the sustained commitment of the global community.
